Background
The Royal College of Ophthalmologists recently published evidence-based guidance on commissioning for cataract surgery 1 in response to reports of wide geographical variation in access to cataract surgery in England [2] [3] [4] and the increasing use of arbitrary Snellen visual acuity thresholds to govern access to cataract surgery. 2 This article summarises the main findings of the Commissioning Guidance and current issues surrounding cataract surgery provision in the NHS. The methodology used to develop this guidance was granted National Institute for Health and Care Excellence (NICE) accreditation in July 2015.
Methodology
The Cataract Surgery Commissioning Guidance was developed in accordance with the Royal College of Ophthalmologists Commissioning Guidance Process Manual. 5 The Guideline Development Group reached consensus on the topics to be covered and the questions to be answered by the Guidance and a systematic search of the literature was undertaken to address these. Searches were made of the Cochrane Libraries, MEDLINE, EMBASE, NHS Evidence-guidelines, NHS Evidence-commissioning, National Guidelines Clearing House, Google and other grey literature including the Royal College of Ophthalmologists and College of Optometrists websites. The guidance does not apply to cataract surgery under the age of 18 years or that where the primary aim is correction of refractive error.
Epidemiology and risk factors for cataract
Cataract is the leading cause of blindness in the world. 6 Cataract surgery is currently the only effective treatment to improve or maintain vision and is the most commonly performed elective surgical procedure in the UK with around 330 000 cataract operations performed per year in England in recent years. 7 The requirement for cataract surgery is anticipated to increase with increasing life expectancy and a growing population. 8 There are no recent estimates for cataract surgery rates based on need. However, overall crude estimates based on current demand from Hospital Episode Statistics data suggests surgery incidence rates of~530 per 100 000 population or 3200 per 100 000 for those over 65 years old per year in recent years (2011 data). 9, 10 Risk factors for cataract include increasing age, diabetes mellitus, corticosteroid use, female gender, socioeconomic status, ethnicity, smoking and alcohol. 11, 12 Some populations have a high prevalence of cataract; for example, 77% of British people aged 42 years old or more originating from the Indian subcontinent have cataract. 12 Cataract surgery Cataract surgery is associated with improvements in visual acuity, contrast sensitivity, depth perception, activity, anxiety, depression, visual disability, confidence, handicap and quality of life and reduction in falls. [13] [14] [15] Cataract surgery is generally reported to be highly cost effective [16] [17] [18] [19] and even in populations with mildly visually impairing cataract (baseline visual acuity 6/12 or better in 75% patients) it is estimated to be cost effective with an incremental cost per quality adjusted life year of £13 172 over an individual's lifetime (assuming an anticipated lifespan of 10 years following surgery). 20 Overall cataract surgery is, for example, reported to be comparable to hip replacement in cost effectiveness. 18 Approximately 40% patients undergo cataract surgery on both eyes. 7, 21 A systematic review 22 funded by the National Institute for Health Research concluded that second eye cataract surgery was associated with a clinically meaningful improvement in stereopsis (depth perception), but did not affect other measures of visual acuity or visual function or health related quality of life, apart from an improvement in the mental health component of health related quality of life in one randomised controlled trial. Second eye cataract surgery was reported to be generally cost effective and the probability of cost effectiveness at willingness-to-pay thresholds of £10 000 and £20 000 was 100%. A detailed analysis of patients who were unhappy with their vision after their first cataract operation found that anisometropia and cataract in the fellow eye accounted for more than a third of such cases. 23 Thresholds for cataract surgery Historically, 'cataract causing visual impairment' was defined as a visual acuity in one or both eyes poorer than 6/12 where the impairment was attributable to lens opacity. 24 This level is no longer considered an appropriate threshold for surgical intervention because of the need for higher visual function to maintain independence, including that for driving, rising patient expectations and advances in surgical technique. 25 Significant improvements in visual symptoms and visual function may occur following cataract surgery even where the preoperative visual acuity is 6/6 or better. However, the risk of worse visual acuity after surgery also increases where the preoperative visual acuity is very good, 7,21,26 so surgery should be considered at this level of visual acuity only where the patient is experiencing significant symptoms attributable to cataract.
The Royal College of Ophthalmologists' National Ophthalmology Database shows that, for the period 2006-2010, 3%, 5% and 36% of eyes undergoing cataract surgery have preoperative visual acuities of better than or equal to 0.00, 0.18 and 0.30 logMAR respectively (equivalent to 6/6, 6/9 and 6/12 Snellen) 7 indicating that before restrictions on access to cataract surgery based on visual acuity were commonplace, eyes with 6/9 or better preoperative visual acuities accounted for only 1 in every 20 cataract surgeries.
Although visual acuity remains a useful component of the assessment of visual disability from cataract, cataract surgery should be considered in the first eye or second eye of a patient who has disabling visual symptoms attributable to cataract. For instance, a patient who experiences disabling glare due to cataract when driving may still achieve a visual acuity of better than 6/9 under ideal conditions of illumination.
In patients with learning disability or cognitive impairment for other reasons, it may not be possible to measure visual acuity, and in this situation, clinicians will need to base the clinical decision to offer surgery on the history and clinical examination findings.
There
Recommended high-quality cataract care pathway A high-quality cataract care pathway should provide equity of access based on the needs of individual patients. An exemplar care pathway for cataract surgery has previously been published by the NHS Institute for Innovation and Improvement. 33 Treatment pathways must be personalised to the patient and adaptable for patients with specific needs. For example 4-5% of patients undergoing cataract surgery require general anaesthesia. 7, 21 Although cataract surgery is generally safe, the risk of operative complications and a poor visual outcome can vary by 10-fold or more depending on the presence of a range of common ocular and systemic risk factors; 34 therefore, it is important that the final decision to operate and individualised planning of care is undertaken by the cataract surgical team. Appropriate provision should be made for intraoperative and postoperative complications which may occasionally arise. The cataract surgery care pathway should support high-quality training and continuing professional development of the professionals who contribute to it.
Quality dashboard for cataract surgery Providers of cataract care should be able to supply data on surgical outcomes to allow monitoring of the clinical care provided. In cataract services where community Optometrists are contracted to undertake the final postoperative assessment, there should be a mechanism for feedback of visual and refractive outcome data and patient satisfaction to the surgical team. For aspects of care where continuous audit is not practical, periodic sampling audit may be indicated.
The benchmark data in Table 1 are derived from large case series and summarise the mean and distribution of significant complications of cataract surgery, visual and refractive outcomes.
These outcomes are influenced by case-mix and, therefore, figures, which appear to deviate significantly or persistently from the mean do not therefore necessarily indicate a cause for concern, but should prompt further analysis. Posterior capsule rupture (PCR) during cataract surgery has been shown to be the only modifiable risk factor for a poor visual outcome 34 and the occurrence of PCR is associated with increasing age, male sex, diabetic retinopathy, glaucoma, longer axial length, advanced cataract and trainee surgeons. 36 
Patient reported outcome measures (PROMs)
There is currently no widely validated PROM for cataract surgery. Based on a systematic review and study of cataract PROMs, the Catquest-9SF questionnaire currently appears to be the most promising instrument. 37, 38 A National Institute for Health Research (NIHR) applied cataract research programme is currently funded to develop a cataract PROM suitable for use in the NHS. 39 
New devices and techniques in cataract surgery
Phacoemulsification is the standard surgical technique used in over 99.7% cataract operations 21 with implantation of a monofocal intraocular lens. Some providers may offer variants although there is no additional NHS tariff for these.
(i) Toric intraocular lens A systematic review found that toric intraocular lenses result in increased unaided distance visual acuity. 40 (ii) Multifocal and accommodating intraocular lens A Cochrane review concluded that multifocal IOLs were effective at improving near vision without any adverse effect on distance visual acuity. However there was an associated reduction in contrast sensitivity and increased risk of perception of halos. 41 NICE guidance recommends special arrangements for patient selection, preoperative counselling and consent beyond that required for monofocal IOLs. 42, 43 Proportion achieving 6/12 or better best measured (with pre-existing ocular co-pathology) 80% 7, 21 Proportion achieving 6/6 best measured (no pre-existing ocular co-pathology) 51% 7,21 Proportion achieving 6/6 best measured (with pre-existing ocular co-pathology) 30 to 33% 7, 21 a Posterior capsule tear rates will vary with the proportion of patients with ocular copathology.
(iii) Laser-assisted cataract surgery Lasers can automate some of the steps of cataract surgery with greater precision and consistency than can be achieved by a surgeon. The conclusions from an earlier NIHR Horizon Scanning Centre briefing are still valid, namely further research is needed to determine the effectiveness and long-term safety profile of laser-assisted cataract surgery compared with current techniques. 44 Summary K The presence of cataract causes disability and increases the likelihood that individuals will suffer adverse events such as falls.
K Cataract surgery is the only effective intervention to treat cataracts and is cost effective.
K Until better measures have been validated, simple thresholds for surgery based on symptoms and visual acuity as described in the document provide a reasonable basis on which to offer surgery for the majority of patients.
K Where an individual has cataract in both eyes, cataract surgery should be offered for both eyes.
K Cataract surgery care pathways must be personalised to the patient and adaptable for patients with specific needs.
K The risk of a poor outcome from cataract surgery is generally low but can be increased substantially by a range of systemic and ocular risk factors, many of which can be mitigated by careful preoperative planning.
K Outcome measures of cataract surgery such as visual acuity, accuracy of refractive correction, occurrence of significant operative and postoperative complications should be recorded routinely. The data should be available to care providers and commissioners.
K Commissioning of cataract care should encompass the whole cataract care pathway from initial assessment and treatment planning to final postoperative review.
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